These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31047074)

  • 1. Amphipathic chitosans improve the physicochemical properties of siRNA-chitosan nanoparticles at physiological conditions.
    Martins GO; Segalla Petrônio M; Furuyama Lima AM; Martinez Junior AM; de Oliveira Tiera VA; de Freitas Calmon M; Leite Vilamaior PS; Han SW; Tiera MJ
    Carbohydr Polym; 2019 Jul; 216():332-342. PubMed ID: 31047074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diethylaminoethyl- chitosan as an efficient carrier for siRNA delivery: Improving the condensation process and the nanoparticles properties.
    de Souza RHFV; Picola IPD; Shi Q; Petrônio MS; Benderdour M; Fernandes JC; Lima AMF; Martins GO; Martinez Junior AM; de Oliveira Tiera VA; Tiera MJ
    Int J Biol Macromol; 2018 Nov; 119():186-197. PubMed ID: 30031084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical characterization of nanoparticles formed between DNA and phosphorylcholine substituted chitosans.
    Casé AH; Dalla Picola IP; Zaniquelli ME; Fernandes JC; Taboga SR; Winnik FM; Tiera MJ
    J Colloid Interface Sci; 2009 Aug; 336(1):125-33. PubMed ID: 19446829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Degree of Ionization and PEGylation on the Stability of Nanoparticles of Chitosan Derivatives at Physiological Conditions.
    Martinez Junior AM; Lima AMF; Martins GO; Tiera VAO; Benderdour M; Fernandes JC; Tiera MJ
    Mar Drugs; 2022 Jul; 20(8):. PubMed ID: 35892944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
    Essa S; Rabanel JM; Hildgen P
    Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers.
    Raja MA; Katas H; Jing Wen T
    PLoS One; 2015; 10(6):e0128963. PubMed ID: 26068222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biophysical properties of chitosan/siRNA polyplexes: profiling the polymer/siRNA interactions and bioactivity.
    Holzerny P; Ajdini B; Heusermann W; Bruno K; Schuleit M; Meinel L; Keller M
    J Control Release; 2012 Jan; 157(2):297-304. PubMed ID: 21884740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine-tuned PEGylation of chitosan to maintain optimal siRNA-nanoplex bioactivity.
    Guţoaia A; Schuster L; Margutti S; Laufer S; Schlosshauer B; Krastev R; Stoll D; Hartmann H
    Carbohydr Polym; 2016 Jun; 143():25-34. PubMed ID: 27083340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan-lipid nanoparticles (CS-LNPs): Application to siRNA delivery.
    Tezgel Ö; Szarpak-Jankowska A; Arnould A; Auzély-Velty R; Texier I
    J Colloid Interface Sci; 2018 Jan; 510():45-56. PubMed ID: 28934610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox-triggered intracellular siRNA delivery.
    Mutlu Agardan NB; Sarisozen C; Torchilin VP
    Chem Commun (Camb); 2018 Jun; 54(49):6368-6371. PubMed ID: 29869650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan derivatives for gene transfer: effect of phosphorylcholine and diethylaminoethyl grafts on the in vitro transfection efficiency.
    Picola IP; Shi Q; Fernandes JC; Petrônio MS; Lima AM; de Oliveira Tiera VA; Tiera MJ
    J Biomater Sci Polym Ed; 2016 Nov; 27(16):1611-30. PubMed ID: 27532422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
    Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
    Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of an environmentally friendly octenylsuccinic anhydride modified pH-sensitive chitosan nanoparticle drug delivery system to alleviate inflammation and oxidative stress.
    Yu Z; Ma L; Ye S; Li G; Zhang M
    Carbohydr Polym; 2020 May; 236():115972. PubMed ID: 32172827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nebulised siRNA encapsulated crosslinked chitosan nanoparticles for pulmonary delivery.
    Sharma K; Somavarapu S; Colombani A; Govind N; Taylor KM
    Int J Pharm; 2013 Oct; 455(1-2):241-7. PubMed ID: 23876499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo therapeutic efficacy of TNFα silencing by folate-PEG-chitosan-DEAE/siRNA nanoparticles in arthritic mice.
    Shi Q; Rondon-Cavanzo EP; Dalla Picola IP; Tiera MJ; Zhang X; Dai K; Benabdoune HA; Benderdour M; Fernandes JC
    Int J Nanomedicine; 2018; 13():387-402. PubMed ID: 29391796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
    Liu X; Howard KA; Dong M; Andersen MØ; Rahbek UL; Johnsen MG; Hansen OC; Besenbacher F; Kjems J
    Biomaterials; 2007 Feb; 28(6):1280-8. PubMed ID: 17126901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat brain.
    Hanafy AS; Farid RM; ElGamal SS
    Drug Dev Ind Pharm; 2015; 41(12):2055-68. PubMed ID: 26133084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
    Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
    Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan nanoparticles for siRNA delivery: optimizing formulation to increase stability and efficiency.
    Ragelle H; Riva R; Vandermeulen G; Naeye B; Pourcelle V; Le Duff CS; D'Haese C; Nysten B; Braeckmans K; De Smedt SC; Jérôme C; Préat V
    J Control Release; 2014 Feb; 176():54-63. PubMed ID: 24389132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.